Immediate Effects of Self-myofascial Release on Latent Trigger Point Sensitivity
NCT ID: NCT02609412
Last Updated: 2016-05-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2015-05-31
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Healthy patients with LMTRP in the calf are randomly allocated to one of three groups: 1) 90s static compression of the most sensitive LMTRP by means of the foam roll, 2) dynamic self-myofascial release rolling back and forth on the calf muscles for 90s using a foam roller, 3) placebo laser acupuncture of the most sensitive LMTRP. All subjects participate in a familiarization session with the foam roller one week prior to treatments. As an outcome, pressure pain threshold is assessed with an algometer. The investigators hypothesize, that static compression can reduce pressure pain of LMTRP more effective than dynamic self-myofascial release. The investigators further expect that placebo treatment will be the least effective method.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Transverse Friction Massage in Latent Myofascial Trigger Points in Anterior Deltoid Muscle
NCT01275482
Time Effect of the Pressure Release Technique Application in the Latent Myofascial Trigger Points
NCT03006822
Effects on Neuromuscular Function After Dry Needling in Myofascial Trigger Points in the Gastrocnemius Muscles
NCT04851743
Muscle Energy Technique and Foam Roller Self Myofascial Release in Two-wheeler Riders With Chronic Low Back Pain
NCT06017804
Latent Myofascial Trigger Points in the Craniocervical Region
NCT03327545
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Static compression of LMTRP
static compression of most sensitive LMTRP with the foam roll for 90 seconds
Static compression of LMTRP
Static compression of most sensitive Triggerpoint with a foam roller (Blackroll Inc., Germany).
Dynamic self-myofascial release of calf
dynamic self-myofascial release rolling back and forth on the entire calf for 90 seconds with the foam roll
Dynamic self-myofascial release of calf
Dynamic self-massage of the calf with a foam roller (Blackroll Inc., Germany).
Placebo laser acupuncture of LMTRP
placebo laser acupuncture applied on most sensitive LMTRP of the calf, light and acoustic sounds provided, but laser remains switched off, 90 seconds
Placebo laser acupuncture of LMTRP
Used device: Laserneedle System (Laserneedle Systems GmbH, Glienicke/Nordbahn, Germany). Electrodes positioned on skin but device remains switched off.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Static compression of LMTRP
Static compression of most sensitive Triggerpoint with a foam roller (Blackroll Inc., Germany).
Dynamic self-myofascial release of calf
Dynamic self-massage of the calf with a foam roller (Blackroll Inc., Germany).
Placebo laser acupuncture of LMTRP
Used device: Laserneedle System (Laserneedle Systems GmbH, Glienicke/Nordbahn, Germany). Electrodes positioned on skin but device remains switched off.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 18 to 65 years
* written informed consent
Exclusion Criteria
* regular intake of drugs or within past 48 hours
* severe psychiatric, neurological, orthopaedic, cardiovascular or endocrine diseases
* pregnancy or nursing period
* any condition that negatively influences current quality of life
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Goethe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Dr. Winfried Banzer
Head of Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Winfried Banzer, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Sports Medicine, Goethe University Frankfurt/Main
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Goethe University Frankfurt/Main
Frankfurt am Main, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SpM2015-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.